JP2011515499A5 - - Google Patents

Download PDF

Info

Publication number
JP2011515499A5
JP2011515499A5 JP2011502107A JP2011502107A JP2011515499A5 JP 2011515499 A5 JP2011515499 A5 JP 2011515499A5 JP 2011502107 A JP2011502107 A JP 2011502107A JP 2011502107 A JP2011502107 A JP 2011502107A JP 2011515499 A5 JP2011515499 A5 JP 2011515499A5
Authority
JP
Japan
Prior art keywords
compound according
glycan
collagen
sequence
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011502107A
Other languages
English (en)
Other versions
JP5740301B2 (ja
JP2011515499A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/038624 external-priority patent/WO2009120995A2/en
Publication of JP2011515499A publication Critical patent/JP2011515499A/ja
Publication of JP2011515499A5 publication Critical patent/JP2011515499A5/ja
Application granted granted Critical
Publication of JP5740301B2 publication Critical patent/JP5740301B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (16)

  1. nが1〜10であり;
    xが、1〜10であり;
    Pが、コラーゲン結合ドメインの配列を含む約5〜約40個のアミノ酸の合成ペプチドであり;そして
    Gがグリカンである、
    式:Pの化合物。
  2. nが1〜5であり;
    xが、1〜10であり;
    Pが、コラーゲン結合ドメインの配列を含む約5〜約40個のアミノ酸の合成ペプチドであり;
    Lがリンカーであり;そして
    Gがグリカンである、
    式:(PL)Gの化合物。
  3. nが1〜5であり;
    xが、1〜10であり;
    Pが、コラーゲン結合ドメインの配列を含む約5〜約40個のアミノ酸の合成ペプチドであり;
    Lがリンカーであり;そして
    Gがグリカンである、
    式:P(LGの化合物。
  4. グリカンがグリコサミノグリカン又は多糖である、請求項1〜3のいずれか1項に記載の化合物。
  5. 合成ペプチドが、小型ロイシンリッチプロテオグリカン又は血小板コラーゲンレセプター配列のアミノ酸配列とのアミノ酸相同性を有する、請求項1〜4のいずれか1項に記載の化合物。
  6. 合成ペプチドが、血小板コラーゲンレセプター配列のアミノ酸配列とのアミノ酸相同性を有する、請求項1〜4のいずれか1項に記載の化合物。
  7. ペプチドが、RRANAALKAGELYKSILYGC、RLDGNEIKRGC、AHEEISTTNEGVMGC、NGVFKYRPRYFLYKHAYFYPPLKRFPVQGC、CQDSETRTFY、TKKTLRTGC、GLRSKSKKFRRPDIQYPDATDEDITSHMGC、SQNPVQPGC、SYIRIADTNITGC、SYIRIADTNIT、KELNLVYT、KELNLVYTGC、GSITTIDVPWNV、及びGSITTIDVPWNVGCからなる群より選択されるアミノ酸配列を含む、請求項1〜4のいずれか1項に記載の化合物。
  8. グリカンが、アルギン酸塩、アガロース、デキストラン、コンドロイチン、デルマタン、デルマタン硫酸、ヘパラン、ヘパリン、ケラチン、及びヒアルロナンからなる群より選択される、請求項1〜7のいずれか1項に記載の化合物。
  9. グリカンが、デルマタン硫酸、デキストラン、及びヘパリンからなる群より選択される、請求項1〜8のいずれか1項に記載の化合物。
  10. リンカーが、式:−SCHCHC(O)NHN=を含む、請求項1〜9のいずれか1項に記載の化合物。
  11. 請求項1〜10のいずれか1項に記載の化合物と、1つ以上の薬学的に許容される賦形剤若しくは希釈剤又はそれらの組み合わせとを含む組成物。
  12. 局所使用に適合された形態の、請求項11記載の組成物。
  13. 局所用形態が、粉末剤、ゲル剤、クリーム剤、軟膏剤、プラスター剤、及び局所液剤からなる群より選択される、請求項12記載の組成物。
  14. 非経口投与に適合された、請求項11記載の組成物。
  15. 非経口投与が、静脈内又は動脈内への投与である、請求項14記載の組成物。
  16. コラーゲンへの接触及び結合並びに血小板活性化の阻害に使用するための、コラーゲン結合性合成ペプチドグリカン。
JP2011502107A 2008-03-27 2009-03-27 コラーゲン結合性合成ペプチドグリカン、調製及び使用方法 Active JP5740301B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US3993308P 2008-03-27 2008-03-27
US61/039,933 2008-03-27
US8198408P 2008-07-18 2008-07-18
US61/081,984 2008-07-18
PCT/US2009/038624 WO2009120995A2 (en) 2008-03-27 2009-03-27 Collagen-binding synthetic peptidoglycans, preparation, and methods of use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015017740A Division JP6049773B2 (ja) 2008-03-27 2015-01-30 コラーゲン結合性合成ペプチドグリカン、調製及び使用方法

Publications (3)

Publication Number Publication Date
JP2011515499A JP2011515499A (ja) 2011-05-19
JP2011515499A5 true JP2011515499A5 (ja) 2012-05-24
JP5740301B2 JP5740301B2 (ja) 2015-06-24

Family

ID=41114790

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011502107A Active JP5740301B2 (ja) 2008-03-27 2009-03-27 コラーゲン結合性合成ペプチドグリカン、調製及び使用方法
JP2015017740A Active JP6049773B2 (ja) 2008-03-27 2015-01-30 コラーゲン結合性合成ペプチドグリカン、調製及び使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015017740A Active JP6049773B2 (ja) 2008-03-27 2015-01-30 コラーゲン結合性合成ペプチドグリカン、調製及び使用方法

Country Status (15)

Country Link
US (4) US8846003B2 (ja)
EP (1) EP2280720B1 (ja)
JP (2) JP5740301B2 (ja)
AU (4) AU2009228140B2 (ja)
CA (1) CA2719254C (ja)
CY (1) CY1121954T1 (ja)
DK (1) DK2280720T3 (ja)
ES (1) ES2720368T3 (ja)
HR (1) HRP20190691T1 (ja)
HU (1) HUE044239T2 (ja)
LT (1) LT2280720T (ja)
PL (1) PL2280720T3 (ja)
PT (1) PT2280720T (ja)
SI (1) SI2280720T1 (ja)
WO (1) WO2009120995A2 (ja)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7015037B1 (en) 1999-08-05 2006-03-21 Regents Of The University Of Minnesota Multiponent adult stem cells and methods for isolation
AU2009205886B2 (en) 2008-01-18 2015-08-27 Katholieke Universiteit Leuven Stem cell aggregates and methods for making and using
SI2280720T1 (sl) 2008-03-27 2019-06-28 Purdue Research Foundation Sintetični peptidoglikani,ki vežejo kolagen, priprava in postopki uporabe
WO2010129547A1 (en) * 2009-05-04 2010-11-11 Purdue Research Foundation Collagen-binding synthetic peptidoglycans for wound healing
MX2012010681A (es) * 2010-03-19 2012-10-09 Otsuka Pharma Co Ltd Conjunto de microagujas que comprenden proteoglicano.
ES2742218T3 (es) * 2010-06-23 2020-02-13 Purdue Research Foundation Peptidoglicanos sintéticos que se enlazan al colágeno destinados a ser utilizados en operaciones vasculares
WO2012112767A2 (en) * 2011-02-16 2012-08-23 Purdue Research Foundation Collagen-targeted nanoparticles
RU2617844C2 (ru) * 2011-05-24 2017-04-28 СИМИК АйПи, ЭлЭлСи Связывающие гиалуроновую кислоту синтетические пептидогликаны, получение и способы использования
JP6603650B2 (ja) 2013-03-15 2019-11-06 パーデュー・リサーチ・ファウンデーション 細胞外マトリックス結合性合成ペプチドグリカン
US20150044259A1 (en) * 2013-08-08 2015-02-12 Mauris N. DeSilva Scaffold for enhanced neural tissue regeneration
US10772931B2 (en) 2014-04-25 2020-09-15 Purdue Research Foundation Collagen binding synthetic peptidoglycans for treatment of endothelial dysfunction
US10828370B2 (en) 2014-05-12 2020-11-10 Purdue Research Foundation Selectin and ICAM/VCAM peptide ligand conjugates
WO2016061145A1 (en) 2014-10-13 2016-04-21 Symic Biomedical, Inc. Synthetic proteoglycans for preventing tissue adhesion
WO2016061147A1 (en) 2014-10-13 2016-04-21 John Eric Paderi Luminal vessel coating for arteriovenous fistula
WO2016065083A1 (en) 2014-10-21 2016-04-28 Symic Biomedical, Inc. Peptidoglycans comprising collagen-binding peptides for treating gastroesophageal injury
EP3253417B1 (en) 2015-02-06 2023-06-21 The University Of British Columbia Engineered tissue substitute system
US20190060516A1 (en) * 2015-08-17 2019-02-28 The Johns Hopkins University In situ forming composite material for tissue restoration
TW201718028A (zh) 2015-10-13 2017-06-01 賽米克Ip有限責任公司 Ve-鈣黏蛋白結合性生物結合物
KR101807593B1 (ko) 2015-12-30 2017-12-11 포항공과대학교 산학협력단 흉터 최소화 상처 재생 촉진용 재조합 폴리펩타이드 및 이를 포함하는 생체 접착 소재
US11896642B2 (en) 2017-07-07 2024-02-13 Symic Holdings, Inc. Bioconjugates with chemically modified backbones
AU2018298224A1 (en) * 2017-07-07 2020-01-30 Symic Ip, Llc Synthetic bioconjugates
AU2019267711A1 (en) 2018-05-09 2020-12-03 The Johns Hopkins University Nanofiber-hydrogel composites for cell and tissue delivery

Family Cites Families (148)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683298A (en) * 1985-01-10 1987-07-28 British Columbia Research Council Process for the preparation of aminated polysaccharide derivatives
US5547936A (en) 1985-06-17 1996-08-20 La Jolla Cancer Research Foundation Inhibition of cell migration with synthetic peptides
JPH04503951A (ja) 1988-12-20 1992-07-16 ラ ホヤ キャンサー リサーチ ファウンデーション 創傷治癒に活性のあるポリペプチド―ポリマー複合体
US5693625A (en) 1989-03-09 1997-12-02 Therapeutiques Substitutives Method of regenerating cells and tissues using functionalized dextrans
FR2644066B1 (fr) 1989-03-09 1994-05-13 Therapeutiques Substitutives Compositions stabilisees comprenant des fgfs, leur procede d'obtention et leurs applications therapeutiques, chirurgicales et cosmetologiques
US5342830A (en) 1990-11-16 1994-08-30 Cor Therapeutics, Inc. Antithrombosis agents
JPH06504912A (ja) 1991-01-14 1994-06-09 ニューヨーク・ユニバーシティ サイトカイン誘導蛋白質tsg−6、該tsg−6蛋白質をコードするdnaおよび該tsg−6蛋白質の利用
JP2901787B2 (ja) * 1991-07-15 1999-06-07 日本メジフィジックス株式会社 核磁気共鳴造影剤
FR2718023B1 (fr) 1994-03-30 1996-08-14 Paris Val Marne Universite Médicament et composition pharmaceutique pour le traitement de lésions du tractus digestif.
US7045585B2 (en) * 1995-11-30 2006-05-16 Hamilton Civic Hospital Research Development Inc. Methods of coating a device using anti-thrombin heparin
CA2239775C (en) 1995-12-18 2008-07-15 Collagen Corporation Crosslinked polymer compositions and methods for their use
CA2299687C (en) 1997-08-04 2009-10-27 Bio Syntech Ltd. Temperature-controlled ph-dependant formation of ionic polysaccharide gels
US5997895A (en) 1997-09-16 1999-12-07 Integra Lifesciences Corporation Dural/meningeal repair product using collagen matrix
BR9814878A (pt) 1997-11-21 2000-10-03 Genset Sa Sequência genÈmica e polipeptìdeos de chlamydia pneumoniae, fragmentos dos mesmos e usos dos mesmos, em particular para o diagnóstico, a prevenção e o tratamento de infecção
US7691829B2 (en) 1998-03-24 2010-04-06 Petito George D Composition and method for healing tissues
US20050208114A1 (en) 1998-03-24 2005-09-22 Petito George D Composition and method for healing tissues
GB9809951D0 (en) 1998-05-08 1998-07-08 Univ Cambridge Tech Binding molecules
FR2781485B1 (fr) 1998-07-21 2003-08-08 Denis Barritault Polymeres biocompatibles leur procede de preparation et les compositions les contenant
JP3103531B2 (ja) 1998-09-30 2000-10-30 延也 柳内 ヒト尿由来細胞接着糖蛋白質及びその製造方法
US6822071B1 (en) 1998-11-12 2004-11-23 The Regents Of The University Of California Polypeptides from Chlamydia pneumoniae and their use in the diagnosis, prevention and treatment of disease
US6703491B1 (en) 1999-03-17 2004-03-09 Exelixis, Inc. Drosophila sequences
US6864235B1 (en) 1999-04-01 2005-03-08 Eva A. Turley Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans
US20090087878A9 (en) 1999-05-06 2009-04-02 La Rosa Thomas J Nucleic acid molecules associated with plants
US20110214206A1 (en) 1999-05-06 2011-09-01 La Rosa Thomas J Nucleic acid molecules and other molecules associated with plants
FR2794976B1 (fr) 1999-06-16 2004-05-07 Solutions Compositions pharmaceutiques a action cicatrisante ou anti-complementaire comprenant un derive de dextrane
CN1214815C (zh) 1999-09-15 2005-08-17 布鲁斯·H·德伍尔夫森 用于在角膜曲率矫形镜片佩戴期间或之后稳定角膜组织的组合物
FR2799465B1 (fr) 1999-10-12 2004-02-13 Centre Nat Rech Scient Peptides ayant une activite de stimulation de la reponse immunitaire et de regeneration tissulaire
US20030158302A1 (en) 1999-12-09 2003-08-21 Cyric Chaput Mineral-polymer hybrid composition
EP1237585B1 (en) 1999-12-09 2003-06-18 Biosyntech Canada Inc. Mineral-polymer hybrid composition
US7671018B2 (en) 2000-08-30 2010-03-02 University Of Delaware Delivery system for heparin-binding growth factors
US7803905B2 (en) 2000-08-31 2010-09-28 University Of Delaware Bioactive peptide for cell adhesion
AU2002211517A1 (en) * 2000-10-04 2002-04-15 California Institute Of Technology Magnetic resonance imaging agents for in vivo labeling and detection of amyloid deposits
DE60125973D1 (de) 2000-11-15 2007-02-22 Biosyntech Canada Inc Verfahren zur wiederherstellung einer geschädigten bandscheibe
US20040236092A1 (en) 2001-07-13 2004-11-25 Roman Dziarski Peptidologlycan recognition protein encoding nucleic acids and methods of use thereof
CA2455884C (en) * 2001-08-15 2015-09-22 Justin R. Fallon Treatment of muscular dystrophies and related disorders
CA2467049C (en) 2001-11-15 2011-04-12 Abdellatif Chenite Composition and method to homogeneously modify or cross-link chitosan under neutral conditions
US20090158452A1 (en) 2001-12-04 2009-06-18 Johnson Richard G Transgenic plants with enhanced agronomic traits
US20050108791A1 (en) 2001-12-04 2005-05-19 Edgerton Michael D. Transgenic plants with improved phenotypes
US20090100536A1 (en) 2001-12-04 2009-04-16 Monsanto Company Transgenic plants with enhanced agronomic traits
AU2003222258A1 (en) * 2002-03-08 2003-09-22 Zymogenetics, Inc. Inhibitors for use in hemostasis
US7666852B2 (en) 2002-04-22 2010-02-23 Agenta Biotechnologies, Inc. Wound and cutaneous injury healing with a nucleic acid encoding a proteoglycan polypeptide
JP2005185101A (ja) 2002-05-30 2005-07-14 National Institute Of Agrobiological Sciences 植物の全長cDNAおよびその利用
US8673333B2 (en) 2002-09-25 2014-03-18 The Johns Hopkins University Cross-linked polymer matrices, and methods of making and using same
US7862831B2 (en) 2002-10-09 2011-01-04 Synthasome, Inc. Method and material for enhanced tissue-biomaterial integration
US20090183270A1 (en) 2002-10-02 2009-07-16 Adams Thomas R Transgenic plants with enhanced agronomic traits
WO2004033631A2 (en) 2002-10-04 2004-04-22 Regents Of The University Of Minnesota Nucleic acid and polypeptide sequences from lawsonia intracellularis and methods of using
US20050069572A1 (en) 2002-10-09 2005-03-31 Jennifer Elisseeff Multi-layered polymerizing hydrogels for tissue regeneration
FR2846659B1 (fr) 2002-10-30 2005-02-18 Centre Nat Rech Scient Fragments peptidiques du facteur harp inhibant l'angiogenese
US20040127416A1 (en) 2002-11-15 2004-07-01 Massia Stephen P. Therapeutic bioconjugates
EP1660473A2 (en) 2003-03-24 2006-05-31 Luitpold Pharmaceuticals, Inc. Xanthones, thioxanthones and acridinones as dna-pk inhibitors
WO2005019429A2 (en) 2003-08-22 2005-03-03 Potentia Pharmaceuticals, Inc. Compositions and methods for enhancing phagocytosis or phagocyte activity
FR2861308A1 (fr) 2003-10-28 2005-04-29 Organes Tissus Regeneration Re Utilisation de polymeres biocompatibles pour la preparation d'une composition pharmaceutique, dermatologique ou cosmetique destinee a la prevention, au soulagement ou au traitement des genes, desagrements et douleurs
EP2260853B1 (fr) 2003-10-28 2015-10-21 Organes Tissus Régénération Réparation Remplacement Polymères biocompatibles pour une composition médicale
WO2005055800A2 (en) 2003-12-15 2005-06-23 Technion Research & Development Foundation Ltd. Therapeutic drug-eluting endoluminal covering
EP1722834B1 (en) 2003-12-22 2012-06-27 Regentis Biomaterials Ltd. Matrix comprising naturally-occurring crosslinked protein backbone
US7842667B2 (en) 2003-12-22 2010-11-30 Regentis Biomaterials Ltd. Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same
US7709439B2 (en) 2004-02-20 2010-05-04 Boston Scientific Scimed, Inc. Biomaterials for enhanced healing
US20060041961A1 (en) 2004-03-25 2006-02-23 Abad Mark S Genes and uses for pant improvement
WO2005116066A1 (en) 2004-05-31 2005-12-08 National University Of Singapore Peptides derived from decorin leucine rich repeats and uses thereof
US20060075522A1 (en) 2004-07-31 2006-04-06 Jaclyn Cleveland Genes and uses for plant improvement
WO2006036681A2 (en) 2004-09-22 2006-04-06 Cartilix, Inc. Cartilage filling device
EP1804844A4 (en) 2004-09-29 2012-02-29 Univ Singapore COMPOSITE, PROCESS FOR ITS MANUFACTURE AND ITS APPLICATIONS
US20060241022A1 (en) 2004-10-06 2006-10-26 Bowen Benjamin P Selectin targeting bioconjugates
US20080102438A1 (en) 2004-10-27 2008-05-01 Yannas Ioannis V Novel Technique to Fabricate Molded Structures Having a Patterned Porosity
WO2007044026A2 (en) 2004-11-23 2007-04-19 The Johns Hopkins University Compositions comprising modified collagen and uses therefore
WO2006089119A2 (en) 2005-02-18 2006-08-24 Cartilix, Inc. Biological adhesive
WO2006089167A1 (en) 2005-02-18 2006-08-24 Cartilix, Inc. Glucosamine materials
CA2598251A1 (en) 2005-03-04 2006-09-14 Northwestern University Angiogenic heparin binding peptide amphiphiles
GB2424223C (en) 2005-03-07 2011-02-02 Massachusetts Inst Technology Biomaterial.
US8431226B2 (en) 2005-03-30 2013-04-30 Biomet Manufacturing Corp. Coated medical device
US7732427B2 (en) 2005-03-31 2010-06-08 University Of Delaware Multifunctional and biologically active matrices from multicomponent polymeric solutions
US8338390B2 (en) 2005-03-31 2012-12-25 University Of Delaware Multifunctional and biologically active matrices from multicomponent polymeric solutions
US8415325B2 (en) 2005-03-31 2013-04-09 University Of Delaware Cell-mediated delivery and targeted erosion of noncovalently crosslinked hydrogels
US7737131B2 (en) 2005-03-31 2010-06-15 University Of Delaware Multifunctional and biologically active matrices from multicomponent polymeric solutions
US8367639B2 (en) 2005-03-31 2013-02-05 University Of Delaware Hydrogels with covalent and noncovalent crosslinks
EP2478760A1 (en) 2005-05-10 2012-07-25 Monsanto Technology LLC Genes and uses for plant improvement
CA2610791C (en) 2005-06-08 2015-12-01 Cangene Corporation Hyaluronic acid binding peptides enhance host defense against pathogenic bacteria
US20080069774A1 (en) 2005-11-17 2008-03-20 Lance Liotta Proteomic antisense molecular shield and targeting
US20070298071A1 (en) 2006-03-07 2007-12-27 Harley Brendan A Bioactive scaffold for therapeutic and adhesion prevention applications
US20070212385A1 (en) 2006-03-13 2007-09-13 David Nathaniel E Fluidic Tissue Augmentation Compositions and Methods
JP2009529967A (ja) 2006-03-15 2009-08-27 サーモディクス,インコーポレイティド 天然生分解性ポリサッカライドの疎水性誘導体及びそれらの使用
EP2090662A3 (en) 2006-04-05 2012-10-31 Metanomics GmbH Process for the production of a fine chemical
GB0610395D0 (en) * 2006-05-25 2006-07-05 Ge Healthcare Ltd Novel imaging agents
US20090162436A1 (en) 2006-06-14 2009-06-25 Carson Daniel D Compositions and methods for repair of tissues
EP2468300B1 (en) 2006-09-26 2017-12-20 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
US7592009B2 (en) 2006-10-10 2009-09-22 Ecole Polytechnique Federale De Lausanne (Epfl) Polypeptide ligands for targeting cartilage and methods of use thereof
US8114835B2 (en) 2006-11-09 2012-02-14 Northwestern University Self-assembling peptide amphiphiles for tissue engineering
US8114834B2 (en) 2006-11-09 2012-02-14 Northwestern University Self-assembling peptide amphiphiles
WO2008066816A2 (en) 2006-11-28 2008-06-05 The Board Of Trustees Of The University Of Illinois Derivatization or ligaton of peptides
WO2008136869A2 (en) 2006-12-06 2008-11-13 Burnham Institute For Medical Research Methods and compositions related to targeting wounds, regenerating tissue, and tumors
US20080295196A1 (en) 2006-12-06 2008-11-27 Abad Mark S Genes and uses for plant improvement
US20080293640A1 (en) 2007-01-10 2008-11-27 Arizona Board of Regents, A body Corporate, of the State of Arizona, acting for and on behalf of Polypeptide inhibitors of HSP27 kinase and uses therefor
ES2672510T3 (es) 2007-04-16 2018-06-14 Regentis Biomaterials Ltd. Composiciones y procedimientos de formación de andamios
US20100119577A1 (en) 2007-05-06 2010-05-13 Byoung-Hyun Min Therapeutic composite for cartilage disorder using extracellular matrix (ecm) scaffold
WO2008152639A2 (en) 2007-06-12 2008-12-18 Bypass, Inc. Pressure pulse actuating device for delivery systems
US20090075281A1 (en) 2007-07-10 2009-03-19 Regents Of The University Of California Mtbe genes
WO2009042514A1 (en) 2007-09-25 2009-04-02 Integra Lifesciences Corporation Flowable wound matrix and its preparation and use
WO2009048280A2 (en) 2007-10-09 2009-04-16 Postech Academy-Industry Foundation Long acting hyaluronic acid - peptide conjugate
WO2009099580A2 (en) 2008-02-05 2009-08-13 Monsanto Technology, Llc Isolated novel nucleic acid and protein molecules from soy and methods of using those molecules to generate transgenic plants with enhanced agronomic traits
SI2280720T1 (sl) 2008-03-27 2019-06-28 Purdue Research Foundation Sintetični peptidoglikani,ki vežejo kolagen, priprava in postopki uporabe
BRPI0909849A2 (pt) 2008-04-04 2015-10-06 Univ Utah Res Found éteres semi-sintéticos de glicosaminoglicosanos e métodos para fazê-los e usá-los
US8343942B2 (en) 2008-04-04 2013-01-01 University Of Utah Research Foundation Methods for treating interstitial cystitis
US20100004196A1 (en) 2008-06-17 2010-01-07 Hopitaux Universitaires De Geneve Heparan sulfate proteoglycan composition and use thereof
WO2010011857A2 (en) 2008-07-23 2010-01-28 The Johns Hopkins University Parenteral administration of a glucosamine
US20110269208A1 (en) 2008-08-15 2011-11-03 The Trustees Of The University Of Pennsylvania Cross-linked polymer network formed by sequential cross-linking
CN102216460A (zh) 2008-09-17 2011-10-12 希尔雷斯股份有限公司 生物量增加的转基因植物
FR2936247B1 (fr) 2008-09-24 2010-10-22 Ct Hospitalier Universitaire De Dijon Proteines recombinantes a activite hemostatique capables d'induire l'agregation plaquettaire.
US9072688B2 (en) 2008-10-31 2015-07-07 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
WO2010060485A1 (de) 2008-11-28 2010-06-03 Zetascience Gmbh Bioaktives hydrogel
KR101062068B1 (ko) 2008-12-01 2011-09-02 포항공과대학교 산학협력단 유착방지용 조성물
IL195764A0 (en) 2008-12-07 2009-11-18 Technion Res & Dev Foundation Compositions and methods for drug delivery
US9012723B2 (en) 2009-01-16 2015-04-21 Monsanto Technology Llc Isolated novel acid and protein molecules from soy and methods of using those molecules to generate transgene plants with enhanced agronomic traits
FR2943249B1 (fr) * 2009-03-18 2011-08-12 Genethon Utilisation de la decorine pour augmenter la masse musculaire
AU2010234942B2 (en) 2009-03-30 2015-03-05 Nestec S.A. Citrullinated peptides for diagnosing and prognosing rheumatoid arthritis
WO2010115156A2 (en) 2009-04-03 2010-10-07 Synthetic Genomics, Inc. Endophytic fungus and uses therefor
JP2012523463A (ja) 2009-04-13 2012-10-04 ノースウエスタン ユニバーシティ 軟骨再生のための新規なペプチドベースの足場およびその使用方法
FI20095452A0 (fi) 2009-04-23 2009-04-23 Suomen Punainen Risti Veripalv Uudet haaraiset sokerianalyysit
WO2010129547A1 (en) 2009-05-04 2010-11-11 Purdue Research Foundation Collagen-binding synthetic peptidoglycans for wound healing
GB0909671D0 (en) 2009-06-04 2009-07-22 Xention Discovery Ltd Compounds
WO2011057286A1 (en) 2009-11-09 2011-05-12 Drexel University Compositions and methods for treating a disorder or defect in soft tissue
JP2013512924A (ja) 2009-12-04 2013-04-18 ユークリッド システムズ コーポレイション 黄斑変性、糖尿病性網膜症および糖尿病黄斑浮腫の予防および治療のための組成物および方法
CN102762715B (zh) 2009-12-16 2016-06-22 瑞吉恩提斯生物材料有限公司 由聚合物-蛋白质结合物形成的支架,产生该支架的方法及其用途
WO2011094149A1 (en) 2010-01-26 2011-08-04 University Of Utah Research Foundation Methods for treating or preventing the spread of cancer using semi-synthetic glycosaminoglycosan ethers
EP3569241A1 (en) 2010-02-26 2019-11-20 Vascular Biosciences, Inc. Car peptide for homing, diagnosis & targeted therapy for pulmonary and fibrotic disorders
ES2742218T3 (es) * 2010-06-23 2020-02-13 Purdue Research Foundation Peptidoglicanos sintéticos que se enlazan al colágeno destinados a ser utilizados en operaciones vasculares
WO2012112767A2 (en) 2011-02-16 2012-08-23 Purdue Research Foundation Collagen-targeted nanoparticles
US20130101628A1 (en) 2011-04-29 2013-04-25 Northwestern University Novel vegf mimetic peptide-based scaffolds for therapeutic angiogenesis and methods for their use
RU2617844C2 (ru) 2011-05-24 2017-04-28 СИМИК АйПи, ЭлЭлСи Связывающие гиалуроновую кислоту синтетические пептидогликаны, получение и способы использования
US9795686B2 (en) 2012-01-19 2017-10-24 The Johns Hopkins University Biomaterials comprising hyaluronic acid binding peptides and bifunctional biopolymer molecules for hyaluronic acid retention and tissue engineering applications
US9540428B2 (en) 2012-07-03 2017-01-10 Ecole Polytechnique Federale De Lausanne (Epfl) Extracellular matrix heparin-binding domains
US9827321B2 (en) 2012-08-14 2017-11-28 The Trustees Of The University Of Pennsylvania Stabilizing shear-thinning hydrogels
WO2014038866A1 (ko) 2012-09-05 2014-03-13 아주대학교산학협력단 연골세포 유래 세포외 기질막을 이용한 신생혈관질환 치료용 조성물 및 각막 또는 결막 이식재
DE102012108560B4 (de) 2012-09-13 2018-12-20 Leibniz-Institut Für Polymerforschung Dresden E.V. Nichtkovalente selbstorganisierende Hydrogelmatrix für biotechnologische Anwendungen
US10344243B2 (en) 2012-10-19 2019-07-09 Cornell University Biomimetic boundary lubricants for articular cartilage
WO2014071132A1 (en) 2012-11-01 2014-05-08 The Johns Hopkins University Contact lens surface modification with hyaluronic acid (ha) binding peptide for ha accumulation and retention
EP2935589A1 (en) 2012-12-18 2015-10-28 Novartis AG Compositions and methods that utilize a peptide tag that binds to hyaluronan
JP6603650B2 (ja) 2013-03-15 2019-11-06 パーデュー・リサーチ・ファウンデーション 細胞外マトリックス結合性合成ペプチドグリカン
US9543849B2 (en) 2013-04-16 2017-01-10 Panasonic Intellectual Property Management Co., Ltd. Power conversion apparatus, power conversion method, motor system, and three-phase motor
WO2015022326A1 (en) 2013-08-12 2015-02-19 Xiber Science Gmbh Peptides as active agents for treating primary graft dysfunction
DE102013113156A1 (de) 2013-11-28 2015-05-28 Freie Universität Berlin Verbindung und Verfahren zur selektiven Radiomarkierung von Polypeptiden mittels Festphasensynthese
US10772931B2 (en) 2014-04-25 2020-09-15 Purdue Research Foundation Collagen binding synthetic peptidoglycans for treatment of endothelial dysfunction
US10828370B2 (en) 2014-05-12 2020-11-10 Purdue Research Foundation Selectin and ICAM/VCAM peptide ligand conjugates
WO2016061147A1 (en) 2014-10-13 2016-04-21 John Eric Paderi Luminal vessel coating for arteriovenous fistula
WO2016061145A1 (en) 2014-10-13 2016-04-21 Symic Biomedical, Inc. Synthetic proteoglycans for preventing tissue adhesion
WO2016065083A1 (en) 2014-10-21 2016-04-28 Symic Biomedical, Inc. Peptidoglycans comprising collagen-binding peptides for treating gastroesophageal injury
WO2016161333A2 (en) 2015-04-01 2016-10-06 Purdue Research Foundation Compositions comprising bioconjugates
CN107771085A (zh) 2015-04-17 2018-03-06 斯米克Ip有限公司 生物缀合物及其用途
TW201718028A (zh) 2015-10-13 2017-06-01 賽米克Ip有限責任公司 Ve-鈣黏蛋白結合性生物結合物

Similar Documents

Publication Publication Date Title
JP2011515499A5 (ja)
HRP20190691T1 (hr) Sintetički peptidoglikani koji vezuju kolagen, priprema, i postupci upotrebe
JP2010215657A5 (ja)
Ouasti et al. The CD44/integrins interplay and the significance of receptor binding and re-presentation in the uptake of RGD-functionalized hyaluronic acid
FI2049506T4 (fi) Lääkkeellisten aineiden farmakokineettisten ominaisuuksien modulaattorit
EA201491441A1 (ru) Композиции конъюгата xten и способы их получения
NZ624749A (en) A sulfated polysaccharide compound and the preparation and use thereof
JP2016516065A5 (ja)
WO2007102149A3 (en) Hydrazido derivatives of hyaluronic acid
TR201900176T4 (tr) Anti-TROP2 antikor-ilaç konjugatı.
CY1119899T1 (el) Μη αντιπηκτικες γλυκοζαμιnoγλυκανες που εμπεριεχουν επαναλαμβανομενη μοναδα δισακχαριτη και η ιατρικη τους χρηση
UA117216C2 (uk) Пухлиноасоційований пептид та його застосування
JP2016512425A5 (ja)
JP2018502123A5 (ja)
CY1121466T1 (el) Αντισωματα εναντι προσδεματων υποδοχεα β1 βραδυκινινης
JP2013509861A5 (ja)
JP2017523985A5 (ja)
WO2011101681A3 (en) Disulphide bond-stabilized functional soluble mhc class ii heterodimers
WO2010035122A3 (fr) Complexe constitue d'un polysaccharide et d'une hpb
EA201370060A1 (ru) КЛАТРАТНЫЕ КОМПЛЕКСЫ β-ЦИКЛОДЕКСТРИНА С 1-{[6-БРОМ-1-МЕТИЛ-5-МЕТОКСИ-2-ФЕНИЛТИОМЕТИЛ-1-Н-ИНДОЛ-3-ИЛ]КАРБОНИЛ}-4-БЕНЗИЛПИПЕРАЗИНОМ, ОБЛАДАЮЩИЕ ПРОТИВОВИРУСНОЙ АКТИВНОСТЬЮ, ИХ ПОЛУЧЕНИЕ И ПРИМЕНЕНИЕ
AR085961A1 (es) Polisacaridos que poseen dos sitios de union a la antitrombina iii, metodo para prepararlos y composiciones farmaceuticas que los contienen
JP2011528334A5 (ja)
CO6290689A2 (es) Derivados de 1,2,3,4-tetrahidropirrolo[1,2]pirazina-6-carboxamidas y de 2,3,4,5-tetrahidropirrol[1,2][1,4]-diazepina -7-carboxamidas su preparacion y su aplicacion en terapeutica
EA201001354A1 (ru) Толтразурил с улучшенными свойствами растворения
WO2010052243A3 (en) Neurotensin-derived branched peptides and uses thereof